Glycemic control during TB treatment among Filipinos: The Starting Anti-Tuberculosis Treatment Cohort Study
Open Access
- 2 May 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (5) , e0003156
Abstract
Poor TB treatment outcomes are observed in patients with type 2 diabetes mellitus (DM) comorbidity and glycemic control throughout treatment may play a role. The objective of this study was to investigate glycemic control longitudinally among Filipino adults undergoing TB treatment using mixed-effects linear and logistic regression. Analyses were conducted in 188 DM-TB patients out of 901 enrolled in the Starting Anti-TB Treatment (St-ATT) cohort, with a median baseline glycosylated hemoglobin (HbA1c) of 8.2% (range 4.5–13.3%). Previous versus new DM diagnosis was associated with higher mean HbA1c (worse glycemic control) during treatment, with a smaller effect amongst those with central obesity (coefficient 0.80, 95% confidence interval [CI] 0.26, 1.57,P= 0.043) than amongst those without central obesity (coefficient 3.48, 95% CI 2.16, 4.80,P<0.001). In those with a new DM diagnosis, central obesity was associated with higher blood glucose (coefficient 1.62, 95% CI 0.72, 2.53, P = 0.009). Of 177 participants with ≥2 HbA1c results, 40% had uncontrolled glycemia (≥2 HbA1c results ≥8%). Of 165 participants with ≥3 HbA1c results, 29.9% had consistently-controlled glycemia, 15.3% had initially-uncontrolled glycemia, and 18.6% had consistently-uncontrolled glycemia. Previous versus new DM diagnosis and glucose-lowering medication use versus no use were associated with having uncontrolled versus controlled glycemia (adjusted odds ratio [aOR] 2.50 95%CI 1.61, 6.05, P = 0.042; aOR 4.78 95% CI 1.61,14.23, P<0.001) and more likely to have consistently-uncontrolled versus consistently-controlled glycemia (adjusted relative risk ratio [aRRR] 5.14 95% CI 1.37, 19.20, P = 0.015; aRRR 10.24 95% CI 0.07, 0.95, P = 0.003). Relapse cases of TB were less likely than new cases to have uncontrolled (aOR 0.20 95%CI 0.06, 0.63, P = 0.031) or consistently-uncontrolled (aRRR 0.25 95%CI 0.07, 0.95, P = 0.042) versus controlled glycemia. Those with long-term DM, suggested by previous diagnosis, glucose-lowering medication use and possibly central obesity, may require additional support to manage blood glucose during TB treatment.Keywords
Funding Information
- “Doctoral Program for World-leading Innovative and Smart Education” for Global Health
- Ministry of Education, Culture, Sports, Science and Technology (17H04662)
This publication has 69 references indexed in Scilit:
- The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: A randomized trialDiabetes Research and Clinical Practice, 2021
- Associations between BMI, waist circumference, central obesity and outcomes in type II diabetes mellitus: The ACCORD TrialJournal of Diabetes and its Complications, 2020
- Detrimental association between diabetes and tuberculosis: An unresolved double troubleDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018
- Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and DiabetesChest, 2017
- Diabète chez les nouveaux cas de tuberculose pulmonaire à Hanoï, VietnamBulletin de la Société de pathologie exotique, 2015
- Diabetes mellitus and its association with central obesity and disability among older adults: A global perspectiveExperimental Gerontology, 2015
- The effect of diabetic control status on the clinical features of pulmonary tuberculosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the jiangsu province of ChinaClinical Therapeutics, 2010
- Stress hyperglycaemiaThe Lancet, 2009
- Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of QatarDiabetes Research and Clinical Practice, 2009